Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366207692> ?p ?o ?g. }
- W4366207692 endingPage "1252" @default.
- W4366207692 startingPage "1252" @default.
- W4366207692 abstract "Lung cancer (LC) represents the second most diagnosed tumor and the malignancy with the highest mortality rate. In recent years, tremendous progress has been made in the treatment of this tumor thanks to the discovery, testing, and clinical approval of novel therapeutic approaches. Firstly, targeted therapies aimed at inhibiting specific mutated tyrosine kinases or downstream factors were approved in clinical practice. Secondly, immunotherapy inducing the reactivation of the immune system to efficiently eliminate LC cells has been approved. This review describes in depth both current and ongoing clinical studies, which allowed the approval of targeted therapies and immune-checkpoint inhibitors as standard of care for LC. Moreover, the present advantages and pitfalls of new therapeutic approaches will be discussed. Finally, the acquired importance of human microbiota as a novel source of LC biomarkers, as well as therapeutic targets to improve the efficacy of available therapies, was analyzed. Therapy against LC is increasingly becoming holistic, taking into consideration not only the genetic landscape of the tumor, but also the immune background and other individual variables, such as patient-specific gut microbial composition. On these bases, in the future, the research milestones reached will allow clinicians to treat LC patients with tailored approaches." @default.
- W4366207692 created "2023-04-19" @default.
- W4366207692 creator A5003001775 @default.
- W4366207692 creator A5015437100 @default.
- W4366207692 creator A5019413733 @default.
- W4366207692 creator A5024701147 @default.
- W4366207692 creator A5037053584 @default.
- W4366207692 creator A5053320317 @default.
- W4366207692 creator A5053359938 @default.
- W4366207692 creator A5076971405 @default.
- W4366207692 date "2023-04-16" @default.
- W4366207692 modified "2023-10-16" @default.
- W4366207692 title "Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer" @default.
- W4366207692 cites W1547463098 @default.
- W4366207692 cites W1610342385 @default.
- W4366207692 cites W1846586690 @default.
- W4366207692 cites W1870303472 @default.
- W4366207692 cites W1953677527 @default.
- W4366207692 cites W1968319149 @default.
- W4366207692 cites W1971843650 @default.
- W4366207692 cites W1975568421 @default.
- W4366207692 cites W1976566249 @default.
- W4366207692 cites W1978044919 @default.
- W4366207692 cites W1978177072 @default.
- W4366207692 cites W1982488143 @default.
- W4366207692 cites W1985146743 @default.
- W4366207692 cites W1986412478 @default.
- W4366207692 cites W1990626198 @default.
- W4366207692 cites W1994634031 @default.
- W4366207692 cites W2008183550 @default.
- W4366207692 cites W2019749043 @default.
- W4366207692 cites W2020991861 @default.
- W4366207692 cites W2022307068 @default.
- W4366207692 cites W2024286449 @default.
- W4366207692 cites W2024492396 @default.
- W4366207692 cites W2045883724 @default.
- W4366207692 cites W2049674541 @default.
- W4366207692 cites W2050369944 @default.
- W4366207692 cites W2052546787 @default.
- W4366207692 cites W2055402151 @default.
- W4366207692 cites W2056631765 @default.
- W4366207692 cites W2061278019 @default.
- W4366207692 cites W2066671159 @default.
- W4366207692 cites W2075000534 @default.
- W4366207692 cites W2075215651 @default.
- W4366207692 cites W2097359286 @default.
- W4366207692 cites W2097995306 @default.
- W4366207692 cites W2098414192 @default.
- W4366207692 cites W2099596714 @default.
- W4366207692 cites W2103110584 @default.
- W4366207692 cites W2103447891 @default.
- W4366207692 cites W2104347254 @default.
- W4366207692 cites W2104830962 @default.
- W4366207692 cites W2108012719 @default.
- W4366207692 cites W2110841878 @default.
- W4366207692 cites W2111454041 @default.
- W4366207692 cites W2111662961 @default.
- W4366207692 cites W2113327188 @default.
- W4366207692 cites W2114095518 @default.
- W4366207692 cites W2117669008 @default.
- W4366207692 cites W2120111652 @default.
- W4366207692 cites W2124662474 @default.
- W4366207692 cites W2128385295 @default.
- W4366207692 cites W2136390065 @default.
- W4366207692 cites W2137043950 @default.
- W4366207692 cites W2139804581 @default.
- W4366207692 cites W2144187284 @default.
- W4366207692 cites W2144539352 @default.
- W4366207692 cites W2145411470 @default.
- W4366207692 cites W2148089871 @default.
- W4366207692 cites W2148332636 @default.
- W4366207692 cites W2149120912 @default.
- W4366207692 cites W2154459685 @default.
- W4366207692 cites W2155599713 @default.
- W4366207692 cites W2156353875 @default.
- W4366207692 cites W2160212814 @default.
- W4366207692 cites W2160485650 @default.
- W4366207692 cites W2163351155 @default.
- W4366207692 cites W2163774814 @default.
- W4366207692 cites W2168404690 @default.
- W4366207692 cites W2169624569 @default.
- W4366207692 cites W2182482244 @default.
- W4366207692 cites W2184779060 @default.
- W4366207692 cites W2198093519 @default.
- W4366207692 cites W2232632307 @default.
- W4366207692 cites W2238997491 @default.
- W4366207692 cites W2251438188 @default.
- W4366207692 cites W2263759961 @default.
- W4366207692 cites W2268267848 @default.
- W4366207692 cites W2293531514 @default.
- W4366207692 cites W2296961659 @default.
- W4366207692 cites W2304485006 @default.
- W4366207692 cites W2306024052 @default.
- W4366207692 cites W2327451947 @default.
- W4366207692 cites W2331247167 @default.
- W4366207692 cites W2335671095 @default.
- W4366207692 cites W2393905053 @default.
- W4366207692 cites W2401709539 @default.